CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company
Phathom Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PHAT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 824151574
- Phone
- (877) 742-8466
- Business address
- 100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
- 4 Grant or award Chief Operating Officer acquired 19,500 shares (grant or award)
- 4 Grant or award VP, Chief Accounting Officer acquired 6,000 shares (grant or award)
- 4 Grant or award President and Chief Executive acquired 41,250 shares (grant or award)
- 4 Open-market sale 10% owner sold 1,000,001 shares at an average $20.85 ($20,850,019)
- 4 Open-market sale Director sold 18,000 shares at an average $32.58 ($586,395)
- 4 Open-market sale Director sold 18,000 shares at an average $32.63 ($587,351)
- 4 Open-market sale Director sold 18,000 shares at an average $31.25 ($562,538)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale 10% owner sold 2,609 shares at $35.05 ($91,445)
- 4 Open-market sale 10% owner sold 8,326 shares at an average $35.16 ($292,727)
- 4 Open-market sale Director sold 40,000 shares at an average $34.05 ($1,361,941)
- 4 Open-market sale 10% owner sold 24,501 shares at an average $35.49 ($869,427)
- 4 Open-market sale 10% owner sold 11,048 shares at an average $35.14 ($388,199)
- 4 Open-market sale 10% owner sold 9,394 shares at an average $35.31 ($331,671)
- 4 Open-market sale 10% owner sold 8,703 shares at an average $35.11 ($305,571)
- 4 Open-market sale 10% owner sold 2,826 shares at $35.06 ($99,080)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale 10% owner sold 3,293 shares at an average $35.19 ($115,883)
- 4 Open-market sale 10% owner sold 2,364 shares at an average $35.05 ($82,853)
- 4 Open-market sale 10% owner sold 4,300 shares at $35.18 ($151,274)
Page 8 of 12 · 224 filings